Expression of components of the IGF axis in childhood acute myelogenous leukemia

Pediatric Blood and Cancer

Volumn 50, Issue 1, 2008, Pages 24-28

  Dawczynski, Kristin ^a,c   Steinbach, Daniel ^b   Wittig, Susann ^a   Pfaffendorf, Nadine ^a   Kauf, Eberhard ^a   Zintl, Felix ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Acute myeloid leukemia; Children; Gene expression; Insulin like growth factor; Insulin like growth factor binding protein

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; SOMATOMEDIN BINDING PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW CELL; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE COURSE; GENETIC ANALYSIS; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

CHILD; DISEASE-FREE SURVIVAL; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LEUKEMIA, MYELOID, ACUTE; RNA, MESSENGER;

EID: 36849038342     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21294     Document Type: Article

References (39)

1. Creuzig U, Zimmermann M, Ritter J, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 2005;19:2030-2042.
2. Grimgberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J Cell Physiol 2000;183:1-9.
3. Dupont J, Pierre A, Froment P, et al. The insulin-like growth factor axis in cell cycle progression. Horm Metab Res 2003;35:740-750.
4. Cohick WS, Clemmons DR. The insulin-like growth factors. Annu Rev Physiol 1993;55:131-153.
5. Clemmons DR. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 1997;8:45-62.
6. Drop SL, Schuller AG, Lindenbergh-Kortleve DJ, et al. Structural aspects of the IGFBP family. Growth Regul 1992;2:69-79.
7. Duan C, Xu Q. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 2005;142:44-52.
8. Mohan S, Baylink DJ. IGF-binding proteins are multifunctional and act via IGF-dependent and-independent mechanisms. J Endocrinol 2002;175:19-31.
9. Lee EJ, Mircean C, Shmulevich I, et al. Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol Cancer 2005;4:7.
10. Fottner Ch, Hoeflich A, Wolf E, et al. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis. Horm Metab Res 2004;36:397-405.
11. Yu H, Nicar MR, Shi R, et al. Levels of insulin-like growth factor-I (IGF-I) and IGF-binding proteins -2 and -3 in serial postoperative serum samples and risk of prostate cancer recurrence. Urology 2001;57:471-475.
12. Hettmer S, Dannecker L, Foell J, et al. Effects of insulin-like growth factors and insulin-like growth factor binding protein-2 on the in vitro proliferation of peripheral blood mononuclear cells. Hum Immunol 2005;66:95-103.
13. Elmlinger MW, Sanatani MS, Bell M, et al. Elevated insulin-like growth factor (IGF) binding protein (IGFBP)-2 and IGFBP-4 expression of leukemic T-cells is affected by autocrine/paracrine IGF-II action but not by IGF type I receptor expression. Eur J Endocrinol 1998;138:337-343.
14. Antonov J, Goldstein DR, Oberli A, et al. Reliable gene expression measurements from degraded RNA by quantitative real-time PCR depend on short amplicons and a proper normalization. Lab Invest 2005;1:1-11.
15. Weisser M, Haferlach T, Schoch C, et al. The use of housekeeping genes for real time PCR-based quantification of fusion gene transcripts in acute myeloid leukemia. Leukemia 2004;18:1551-1553.
16. Nickerson T, Huynh H, Pollak M. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. Biochem Biophys Res Commun 1997;237:690-693.
17. Cucuianu A. Pathogenic pathways in acute myeloid leukemias. Rom J Physiol 2004;41:109-118.
18. Rodrigues PC, Oliveira SN, Viana MB, et al. Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia. Pediatr Blood Cancer 2007;49:133-138.
19. Ho PJ, Baxter RC. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostate hyperplasia. Clin Endocrinol (Oxf) 1997;82:2308-2313.
20. Allar MA, Wood TL. Expression of the Insulin-like growth factor binding proteins during postnatal development of the murine mammary gland. Endocrinology 2004;145:2467-2477.
21. Petridou E, Skalkidou A, Dessypris N, et al. Insulin-like growth factor binding protein-3 predicts survival from acute leukemia. Oncology 2001;60:252-257.
22. Dawczynski K, Kauf E, Zintl F. Changes of serum growth factors (IGF-I, -II and IGFBP-2, -3) prior to and after stem cell transplantation in children with acute leukemia. Bone Marrow Transplant 2003;32:411-415.
23. Vorwerk P, Mohnike K, Wex H, et al. Insulin-like growth factor-binding protein-2 at diagnosis of childhood acute lymphoblastic leukaemia and the prediction of relapse risk. J Clin Endocrinol Metab 2005;90:3022-3027.
24. Mohnike K, Kluba U, Mittler U, et al. Serum levels of insulin-like growth factor-I, -II and insulin-like binding proteins-2, -3 in children with acute lymphoblastic leukaemia. Eur J Pediatr 1996;155:81-86.
25. Smith WJ, Underwood LE, Clemmons DR. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab 1995;80:443-449.
26. Nyman T, Pekonen F. The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes. Acta Endocrinol 1993;128:168-172.
27. Menouny M, Binox M, Babajako S. IGFBP-2 expression in human cell line is associated with increased IGFBP-3 proteolysis, decreased IGFBP-1 expression and increased tumorgenicity. Int J Cancer 1998;77:874-879.
28. Buckbinder L, Talbott R, Velasco-Miguel S, et al. The induction of the growth inhibitor IGF-binding protein-3 by p53. Nature 1995;377:646-649.
29. Giovannucci E. Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003;35:694-704. Review
30. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 2006;17:328-336.
31. Batron-Hay S, Boyle F, Ferrier A, et al. Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res 2004;10:1796-1806.
32. Shi LH, Zhu XQ, Zhao GH, et al. Expression of insulin-like growth factor binding protein-2 in gastric carcinoma and its relationship with cell proliferation. World J Gastroenterol 2006;12:6285-6289.
33. Lancaster JM, Sayer RA, Blanchette C, et al. High expression of insulin-like growth factor binding protein-2 messenger RNA in epithelial ovarian cancers produces elevated preoperative serum levels. Int J Gynecol Cancer 2006;16:1529-1535.
34. Boulle N, Logie A, Gicquel NJ, et al. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporatic adrenocortical tumors. J Clin Endocrinol Metab 1998;83:1713-1720.
35. Dawczynski K, Kauf E, Schienvoigt D, et al. Elevated serum insulin-like growth factor binding protein-2 is associated with a high relapse risk after hematopoietic stem cell transplantation in childhood AML. Bone Marrow Transplant 2006;37:589-594.
36. Hattori H, Matsuzaki A, Suminoe A, et al. Identification of novel genes with prognostic value in childhood leukemia using cDNA microarray and quantitative RT-PCR. Pediatr Hematol Oncol 2006;23:115-127.
37. Schutt BS, Langkamp M, Rauschnabel U, et al. Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol 2004;32:859-868.
38. Frommer KW, Reichenmiller K, Schutt BS, et al. IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. J Mol Endocrinol 2006;37:13-23.
39. Bugie-Barhim S, Min HK, Oh P. Potential of proteomics towards the investigation of the independent action of IGFBP-3. Expert Rev Proteom 2005;2:71-86.